Skip to: Curated Story Group 1
healthcarebusinessreview

Advertise

with us

    • US
    • EUROPE
    • APAC
    • CANADA
  • Home
  • Sections
    Business Process Outsourcing
    Compliance & Risk Management
    Consulting Service
    Dental Billing Services
    Facility Management Services
    Financial Services
    Healthcare Digital Marketing
    Healthcare Education
    Healthcare Procurement
    Healthcare Security
    Healthcare Staffing
    Long-Term Care Pharmacy Services
    Medical Billing
    Medical Case Management
    Medical Transportation
    Patient Monitoring
    Practice Management Service
    Real Estate Services
    Supply Chain
    Therapy Services
  • Contributors
  • News
  • Vendors
  • Conferences
  • CXO Awards
Welcome back to this new edition of Healthcare Business Review !!!✖
Sign In

Subscribe to our Weekly Newsletter to get latest updates to your inbox
6 MAY 2024In healthcare, compounding pharmacies stand as pillars of innovation and personalized care. Harnessing the power of customization, these specialized pharmacies play a crucial role in tailoring medications to meet the unique needs of individual patients. From addressing allergies and dosage preferences to creating specialized formulations unavailable in standard pharmaceuticals, compounding pharmacies offer a spectrum of solutions that traditional pharmacies cannot match. The global compounding pharmacy market is poised to reach a valuation of USD 14.82 billion by 2030, at a CAGR of 6.2 percent during the forecast period of 2023 to 2030. This growth trajectory is propelled by the increasing rate of patent expirations, increased life expectancy, and the growing elderly population. This edition of Healthcare Business Review presents a comprehensive overview of the latest developments in the compounding pharmacy sector, shedding light on evolving health strategies, innovations and wellness trends shaping the global landscape. It features insightful articles from industry leaders Nick Capote, systemwide director of oncology, infusion and investigational drug pharmacy services at UCSF Health, and David Short, chief quality officer at QuVa Pharma. Drawing upon his extensive expertise and experience as the health pharmacy director, Nick delves into crucial topics such as pharmaceutical care within an organization. David offers insights into the 503B facility and the intricate link between the pharmacy and the drug manufacturer.This edition spotlights MixMyRx, which offers a favorable patient-centric approach in the pharmacy industry with an innovative business model.We hope this edition of Top Compounding Pharmacy Services Providers 2024 helps you find the appropriate partner to guide you in your compounding pharmacy requirements.Let us know your thoughts!Transforming Healthcare through Personalized MedicineEditorialAlex D'souzaManaging Editoreditor@healthcarebusinessreview.comManaging EditorAlex D'souzaEditorial StaffAaron PaulJoe PhillipJames SmithMark RobertVisualizerCopyright © 2024 ValleyMedia, Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.MAY - 25 - 2024, volume 07 - Issue 17 (ISSN 2836-7030) Published by ValleyMedia, Inc. To subscribe to Healthcare Business ReviewVisit www.healthcarebusinessreview.com Disclaimer : *Some of the Insights are based on our interviews with CIOs and CXOsEmail:sales@healthcarebusinessreview.comeditor@healthcarebusinessreview.commarketing@healthcarebusinessreview.comImmanuelRonald Donovan
< Page 5 | Page 7 >